Dr Elisa Shipon-blum, DO | |
505 Old York Road, Lower Level, Jenkntown, PA 19046 | |
(215) 887-5748 | |
(215) 827-5722 |
Full Name | Dr Elisa Shipon-blum |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 505 Old York Road, Jenkntown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659618858 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS-007431-L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Elisa Shipon-blum, DO 1130 Herkness Drive, Meadowbrook, PA 19046 Ph: (215) 887-5748 | Dr Elisa Shipon-blum, DO 505 Old York Road, Lower Level, Jenkntown, PA 19046 Ph: (215) 887-5748 |
News Archive
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
Carbon dioxide emissions from fossil fuel sources reached a maximum daily decline of 17 per cent in April as a result of drastic decline in energy demand that have occurred during the COVID-19 pandemic.
The International Committee of Medical Journal Editors (ICMJE) today issued a follow-up joint editorial regarding its goal to foster a comprehensive, publicly available database of clinical trials. The joint editorial by 11 ICMJE member journals is published online simultaneously today and is posted on the JAMA website. It will also appear in print in the June 15 issue of JAMA.
The International Myeloma Foundation (IMF) - the oldest and largest foundation dedicated to improving the life and care of myeloma patients - says today's Food and Drug Administration approval of Onyx's Kyprolis (carfilzomib) offers hope to myeloma patients who have run out of options when available therapies have stopped working.
› Verified 4 days ago